Immunotherapy Advances in Colorectal Cancer Treatment
A landmark study demonstrates that pembrolizumab combined with standard chemotherapy significantly extends progression-free survival in patients with mismatch repair-deficient colorectal cancer.
Research Hub
General Cancer Research
Curated cancer research categorised as General Cancer Research. View all research →